Toxicological Sciences 62, 330-338 (2001)
Copyright © 2001 by the Society of Toxicology
RISK ASSESSMENT |
The Frequency of U-Shaped Dose Responses in the Toxicological Literature
Department of Environmental Health Sciences, School of Public Health and Health Sciences, University of Massachusetts, Amherst, Massachusetts 01003
ABSTRACT
Hormesis has been defined as a dose-response relationship in which there is a stimulatory response at low doses, but an inhibitory response at high doses, resulting in a U- or inverted U-shaped dose response. To assess the proportion of studies satisfying criteria for evidence of hormesis, a database was created from published toxicological literature using rigorous a priori entry and evaluative criteria. One percent (195 out of 20,285) of the published articles contained 668 dose-response relationships that met the entry criteria. Subsequent application of evaluative criteria revealed that 245 (37% of 668) dose-response relationships from 86 articles (0.4% of 20,285) satisfied requirements for evidence of hormesis. Quantitative evaluation of false-positive and false-negative responses indicated that the data were not very susceptible to such influences. A complementary analysis of all dose responses assessed by hypothesis testing or distributional analyses, where the units of comparison were treatment doses below the NOAEL, revealed that of 1089 doses below the NOAEL, 213 (19.5%) satisfied statistical significance or distributional data evaluative criteria for hormesis, 869 (80%) did not differ from the control, and 7 (0.6%) displayed evidence of false-positive values. The 32.5-fold (19.5% vs 0.6%) greater occurrence of hormetic responses than a response of similar magnitude in the opposite (negative) direction strongly supports the nonrandom nature of hormetic responses. This study, which provides the first documentation of a data-derived frequency of hormetic responses in the toxicologically oriented literature, indicates that when the study design satisfies a priori criteria (i.e., a well-defined NOAEL, 
2 doses below the NOAEL, and the end point measured has the capacity to display either stimulatory or inhibitory responses), hormesis is frequently encountered and is broadly represented according to agent, model, and end point. These findings have broad-based implications for study design, risk assessment methods, and the establishment of optimal drug doses and suggest important evolutionarily adaptive strategies for dose-response relationships.
Key Words: hormesis; compensatory responses; overcompensation; U-shaped; J-shaped; dose response; low doses; risk assessment; extrapolation.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  B. Morin, L. A. Nichols, K. M. Zalasky, J. W. Davis, J. A. Manthey, and L. J. Holland The Citrus Flavonoids Hesperetin and Nobiletin Differentially Regulate Low Density Lipoprotein Receptor Gene Transcription in HepG2 Liver Cells J. Nutr., July 1, 2008; 138(7): 1274 - 1281. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. E Marchant Hormesis and toxic torts Human and Experimental Toxicology, February 1, 2008; 27(2): 97 - 107. [Abstract] [PDF]
|
|
|
|
|
|
B. D Beck and M. R Seeley Commentary on `Hormesis and toxic torts' Human and Experimental Toxicology, February 1, 2008; 27(2): 115 - 116. [PDF]
|
|
|
|
 |
|
 L. Li, M. E Andersen, S. Heber, and Q. Zhang Non-monotonic dose-response relationship in steroid hormone receptor-mediated gene expression J. Mol. Endocrinol., May 1, 2007; 38(5): 569 - 585. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Hang, Z. Huang, S. Jiang, J. Gong, C. Wang, D. Xie, and H. Ren Apoptosis in pressure overload-induced cardiac hypertrophy is mediated, in part, by adenine nucleotide translocator-1. Ann. Clin. Lab. Sci., December 1, 2006; 36(1): 88 - 95. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. J. Calabrese, J. W. Staudenmayer, E. J. Stanek III, and G. R. Hoffmann Hormesis Outperforms Threshold Model in National Cancer Institute Antitumor Drug Screening Database Toxicol. Sci., December 1, 2006; 94(2): 368 - 378. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Calabrese What is the purpose of a risk assessment? Human and Experimental Toxicology, January 1, 2006; 25(1): 1 - 1. [PDF]
|
|
|
|
|
|
J M DeSesso and R E Watson The case for integrating low dose, beneficial responses into US EPA risk assessments Human and Experimental Toxicology, January 1, 2006; 25(1): 7 - 10. [Abstract] [PDF]
|
|
|
|
|
|
L E Feinendegen and R D Neumann The issue of risk in complex adaptive systems: the case of low-dose radiation induced cancer Human and Experimental Toxicology, January 1, 2006; 25(1): 11 - 17. [Abstract] [PDF]
|
|
|
|
|
|
P F Ricci, L A Cox Jr, and T R MacDonald Science-policy in environmental and health risk assessment: if we cannot do without, can we do better? Human and Experimental Toxicology, January 1, 2006; 25(1): 29 - 43. [Abstract] [PDF]
|
|
|
|
 |
|
 L. E. Feinendegen and R. D. Neumann Physics must join with biology in better assessing risk from low-dose irradiation Radiat Prot Dosimetry, December 1, 2005; 117(4): 346 - 356. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. F Ricci, L. A Cox Jr, and T. R MacDonald Precautionary principles: a jurisdiction-free framework for decision-making under risk Human and Experimental Toxicology, December 1, 2004; 23(12): 579 - 600. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Kinoshita, H. Wanibuchi, K. Morimura, M. Wei, J. Shen, S. Imaoka, Y. Funae, and S. Fukushima Phenobarbital at low dose exerts hormesis in rat hepatocarcinogenesis by reducing oxidative DNA damage, altering cell proliferation, apoptosis and gene expression Carcinogenesis, August 1, 2003; 24(8): 1389 - 1399. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Calabrese and L. A. Baldwin The Hormetic Dose-Response Model Is More Common than the Threshold Model in Toxicology Toxicol. Sci., February 1, 2003; 71(2): 246 - 250. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. J. Calabrese Letter Toxicol. Sci., September 1, 2002; 69(1): 286 - 286. [Full Text] [PDF]
|
|
|
|
|
|
M. Wade Reply Toxicol. Sci., September 1, 2002; 69(1): 286 - 287. [Full Text] [PDF]
|
|
|
|
|
|
D C Christiani and W Zhou Hormesis: the new approach in risk assessment? Human and Experimental Toxicology, July 1, 2002; 21(7): 399 - 400. [Abstract] [PDF]
|
|
|
|
|
|
G Carelli, I Iavicoli, and N Castellino Hormesis and industrial hygiene: a new hypothesis for low-dose response in occupational risk assessment Human and Experimental Toxicology, July 1, 2002; 21(7): 401 - 403. [Abstract] [PDF]
|
|
|
|
|
|
E J Calabrese and L A Baldwin Defining hormesis Human and Experimental Toxicology, February 1, 2002; 21(2): 91 - 97. [Abstract] [PDF]
|
|
|
|
|
|
G Carelli and I Iavicoli Defining hormesis: the necessary tool to clarify experimentally the low dose-response relationship Human and Experimental Toxicology, February 1, 2002; 21(2): 103 - 104. [Abstract] [PDF]
|
|
|
|
|
|
E J Calabrese and L A Baldwin Response to expert commentators Human and Experimental Toxicology, February 1, 2002; 21(2): 113 - 114. [PDF]
|
|
|
|
|
|
E. J. Calabrese and L. A. Baldwin Letter Toxicol. Sci., September 1, 2001; 63(1): 149 - 149. [Full Text] [PDF]
|
|